Drug Utilisation Sub-Committee utilisation analysis public release documents

10 July 2020 - The utilisation analysis public release documents from the February 2020 Drug Utilisation Sub-Committee meeting are now available. ...

Read more →

So just who do we think qualifies for any COVID-19 vaccine?

 9 July 2020 - How should we allocate scarce medical resources? ...

Read more →

Better protection against meningococcal and pneumococcal diseases

6 July 2020 - The National Immunisation Program has been amended from 1 July 2020 to improve protection for those most ...

Read more →

Public Summary Documents - March 2020 PBAC meeting

3 July 2020 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2020 PBAC ...

Read more →

PBS listings to benefit Australians with type 2 diabetes and small cell lung cancer, emergency dispensing measures of PBS medicines extended

30 June 2020 - The importance of the Pharmaceutical Benefits Scheme has been underlined with new and amended medicines listings on ...

Read more →

Schedule of Pharmaceutical Benefits - 1 July 2020

1 July 2020 - The July 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Expansion of continued dispensing arrangements – COVID-19

1 July 2020 - The Australian Government has extended the temporary Continued Dispensing (Emergency Measures) for three months to 30 September ...

Read more →

Price disclosure October 2020 cycle outcomes summary

25 June 2020 - The summary of price disclosure price reductions for the October 2020 Cycle has now been published. ...

Read more →

Seventh Community Pharmacy Agreement

23 June 2020 - The Seventh Community Pharmacy Agreement is commencing 1 July 2020 and will be in place for five ...

Read more →

'This is what life could be like': a miracle migraine drug is changing sufferer's lives but most can't afford the 'exorbitant' $800 a month price tag

20 June 2020 - "I wish people would understand that a migraine is not just a headache. It is so ...

Read more →

Updated PBS cost recovery arrangements for 2020-21

19 June 2020 - The 2020-21 Cost Recovery Implementation Statement is now available. ...

Read more →

Recommendations made by the PBAC – May 2020 intracycle meeting

19 June 2020 - There is actually only one recommendation. ...

Read more →

Additional $92 million, or 5 percent, government funding for pharmaceutical wholesalers

16 June 2020 - Pharmaceutical wholesalers will receive an additional $92 million, or 5 per cent, funding from the federal ...

Read more →

Analysis of PBAC submissions and outcomes for medicines (2010–2018)

11 June 2020 - Sean Lybrand and I reviewed the Pharmaceutical Benefits Advisory Committee submissions and their related outcomes and timelines ...

Read more →

$18.3 billion deal struck to fund Pharmaceutical Benefits Scheme, improve indigenous health

12 June 2020 - The Morrison government will spend an additional $100 million over the next five years on medication ...

Read more →